1. Home
  2. INSW vs NMRA Comparison

INSW vs NMRA Comparison

Compare INSW & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INSW
  • NMRA
  • Stock Information
  • Founded
  • INSW 1999
  • NMRA 2019
  • Country
  • INSW United States
  • NMRA United States
  • Employees
  • INSW N/A
  • NMRA N/A
  • Industry
  • INSW Semiconductors
  • NMRA
  • Sector
  • INSW Technology
  • NMRA
  • Exchange
  • INSW Nasdaq
  • NMRA Nasdaq
  • Market Cap
  • INSW 2.0B
  • NMRA 1.7B
  • IPO Year
  • INSW N/A
  • NMRA 2023
  • Fundamental
  • Price
  • INSW $38.45
  • NMRA $2.05
  • Analyst Decision
  • INSW Strong Buy
  • NMRA Strong Buy
  • Analyst Count
  • INSW 3
  • NMRA 6
  • Target Price
  • INSW $60.67
  • NMRA $20.67
  • AVG Volume (30 Days)
  • INSW 1.4M
  • NMRA 6.3M
  • Earning Date
  • INSW 02-27-2025
  • NMRA 03-06-2025
  • Dividend Yield
  • INSW 15.01%
  • NMRA N/A
  • EPS Growth
  • INSW N/A
  • NMRA N/A
  • EPS
  • INSW 10.33
  • NMRA N/A
  • Revenue
  • INSW $1,007,734,000.00
  • NMRA N/A
  • Revenue This Year
  • INSW N/A
  • NMRA N/A
  • Revenue Next Year
  • INSW $1.61
  • NMRA N/A
  • P/E Ratio
  • INSW $3.72
  • NMRA N/A
  • Revenue Growth
  • INSW N/A
  • NMRA N/A
  • 52 Week Low
  • INSW $32.11
  • NMRA $1.83
  • 52 Week High
  • INSW $65.94
  • NMRA $21.00
  • Technical
  • Relative Strength Index (RSI)
  • INSW 51.17
  • NMRA 20.26
  • Support Level
  • INSW $40.30
  • NMRA $2.12
  • Resistance Level
  • INSW $41.62
  • NMRA $2.44
  • Average True Range (ATR)
  • INSW 1.37
  • NMRA 0.39
  • MACD
  • INSW 0.57
  • NMRA -0.31
  • Stochastic Oscillator
  • INSW 48.44
  • NMRA 2.26

About INSW International Seaways Inc.

International Seaways Inc owns and operates a fleet of oceangoing vessels engaged in the transportation of crude oil and petroleum products. The company's vessel operations are organized into two segments: Crude Tankers and Product Carriers. The fleet consists of ULCC, VLCC, Suezmax, Aframax, and Panamax crude tankers, as well as LR1, LR2, and MR product carriers.

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.

Share on Social Networks: